Esomeprazole: a Safe Alternative to Lansoprazole Allergy?

Esomeprazole: a Safe Alternative to Lansoprazole Allergy?

LETTER TO THE EDITOR

Bibliographic Details
Main Authors:	Muammer Kara, Alpaslan Tanoglu, Ali Kutlu, Ozgur Sirkeci, Murat Kekilli
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2014-08-01
Series:	Iranian Journal of Allergy, Asthma and Immunology
Subjects:	Allergic reactions Esomeprazole Lansoprazole allergy Proton pump inhibitors
Online Access:	https://ijaai.tums.ac.ir/index.php/ijaai/article/view/442

Similar Items

Comparison of the Effect of Omeprazole, Pantoprazole, Esomeprazole, and Lansoprazole on the Reduction of Symptoms in Patients with Gastroesophageal Reflux Disease
by: Nima Arezoomandi, et al.
Published: (2019-02-01)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
by: Hung KT, et al.
Published: (2021-03-01)

Comparative analysis of the effect of PO administered acid suppressants on gastric pH in healthy cats
by: Phillip Ryan, et al.
Published: (2020-09-01)

Esomeprazole-induced lichen planus
by: Miguel Santos-Coelho, et al.
Published: (2023-04-01)

Lansoprazole as an uncommon cause of anaphylaxis: What to give next?
by: Attila Aydın, et al.
Published: (2019-09-01)

Pharmacokinetic Study and Incurred Sample Stability of Esomeprazole in Dried Blood Spot Sample Using High Performance Liquid Chromatography-Photodiode Array
by: Yahdiana Harahap, et al.
Published: (2020-07-01)

Preclinical Evaluation of Esomeprazole Safety and Toxicokinetics
by: V. M. Kosman, et al.
Published: (2023-06-01)

Efficacy of Seven-day High-dose Esomeprazole-based Triple Therapy versus Seven-day Standard Dose Non-esomeprazole-based Triple Therapy as the First-line Treatment of Patients with Helicobacter pylori Infection
by: Young Dal Lee, et al.
Published: (2020-09-01)

Lansoprazole in treatment of duodenal ulcer desease
by: V. V. Skvortsov, et al.
Published: (2019-05-01)

Persistent cutaneous lesion in a child with tyrosinemia: Esomeprazole‐induced lichenoid drug eruptions
by: Bahareh Abtahi‐Naeini, et al.
Published: (2021-08-01)

Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study
by: Hyun Lim, et al.
Published: (2023-12-01)

Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study
by: Ming-Hsun Lin, et al.
Published: (2023-05-01)

Efficacy and Safety of Dual Delayed-Release Formulation of Esomeprazole in Patients with Gastroesophageal Reflux Disease: A Multicenter, Prospective, Observational Study
by: Hyun Lim, et al.
Published: (2025-01-01)

Letter to the editor: lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris
by: Meng Zhu, et al.
Published: (2024-12-01)

Comparison of hepatotoxicity of tegoprazan, a novel potassium-competitive acid blocker, with proton pump inhibitors using real-world data: A nationwide cohort study
by: Min-Gul Kim, et al.
Published: (2023-01-01)

Pharmacokinetics of esomeprazole in goats (Capra aegagrus hircus) after intravenous and subcutaneous administration
by: Rachel Fladung, et al.
Published: (2022-12-01)

Repurposing lansoprazole to alleviate metabolic syndrome via PHOSPHO1 inhibition
by: Yingting Wu, et al.
Published: (2024-04-01)

The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole
Published: (2010-06-01)

Inhibidores de la bomba de protones: el impacto en la salud cognitiva de los adultos mayores
by: Alexander Ramírez Álvarez, et al.
Published: (2024-01-01)

Possibilities for prescribing lansoprazole in the outpatient practice
by: I. G. Pakhomova, et al.
Published: (2019-08-01)

Ratio - First Order Derivative - Zero Crossing UV-Visible Spectrophotometric Method for Analysis of Amoxicillin, Levofloxacin and Lansoprazole Mixture
by: Mustafa Gülfen, et al.
Published: (2020-06-01)

Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey
by: Mustafa Iscan, et al.
Published: (2011-09-01)

Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin
by: Muhammad Israr, et al.
Published: (2022-05-01)

Special review and analysis on the clinical unreasonable use of proton pump inhibitors for injection
by: ZHAO Feng, LU Xinglan, WANG Fang, WANG Jie
Published: (2024-02-01)

Therapeutic Effects of Esomeprazole on Pancreatic and Lung Injury in Acute Pancreatitis: An Experimental Study
by: Yusuf İskender Tandoğan, et al.
Published: (2025-01-01)

Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects
by: Kim HC, et al.
Published: (2023-04-01)

Development of a simple UV-spectrophotometric method for the determination of lansoprazole and study of its degradation profile
by: Zenita Devi Okram, et al.
Published: (2012-01-01)

Effect of Quadruple Regimen with Lansoprazole on Elderly Patients with Chronic Atrophic Gastritis and Its Influence on Gastric Function
by: Zhang Wanglai, et al.
Published: (2024-11-01)

Un ensayo clínico piloto de la efectividad clínica de dos presentaciones de esomeprazol
by: Carlos Arturo Rojas, et al.
Published: (2019-10-01)

Pharmacokinetics and Anti-Gastric Ulceration Activity of Oral Administration of Aceclofenac and Esomeprazole in Rats
by: Tae Hwan Kim, et al.
Published: (2018-09-01)

A Multicenter, Randomized, Comparative Study to Determine the Appropriate Dose of Lansoprazole for Use in the Diagnostic Test for Gastroesophageal Reflux Disease
Published: (2011-09-01)

Box-Behnken Assisted Validation and Optimization of an RP-HPLC Method for Simultaneous Determination of Domperidone and Lansoprazole
by: Mohd Afzal, et al.
Published: (2021-01-01)

Efektivitas Pemberian Antibiotik Disertai Lansoprazol pada Refluks Laringofaring dengan Infeksi Helicobacter pylori
by: Yanti Nurrokhmawati, et al.
Published: (2012-12-01)

The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study
by: Su Jin Hong, et al.
Published: (2016-11-01)

The consequences of long-term therapy with proton pump inhibitors
by: Zuzanna Drygała, et al.
Published: (2024-01-01)

Esomeprazole and apixaban pharmacokinetic interactions in healthy rats
by: Ali Jaber, et al.
Published: (2022-10-01)

A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
by: Tai WC, et al.
Published: (2019-09-01)

Variation in Fatty Acid Synthase, Ki67 and p53 Esophageal Mucosa Expressions in Barrett’s Esophagus Patients Treated for One Year with Two Esomeprazole Different Regimens
by: Pietro Crispino, et al.
Published: (2023-05-01)

Indications, diagnostic tests and Helicobacter pylori eradication therapy: Recommendations by the 2nd Spanish Consensus Conference Indicaciones, métodos diagnósticos y tratamiento erradicador de Helicobacter pylori: Recomendaciones de la II Conferencia Española de Consenso
by: J. Monés, et al.
Published: (2005-05-01)

Development and validation of a high-performance liquid chromatography method for the estimation of esomeprazole in bulk and tablet dosage form
by: Trushal V Chorage, et al.
Published: (2023-11-01)